These results are supported by literature, presenting ApoE4 as a risk factor for AD [24, 44] with the specific effects on Aβ and tau differing between studies, approaches, and brain regions [6, 23, 31, 50, 68]. The gene discussed is MAPT; the disease is Alzheimer disease.